{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:29:27Z","timestamp":1775064567066,"version":"3.50.1"},"reference-count":31,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007686","name":"Instituto Nacional de Perinatolog\u00eda","doi-asserted-by":"publisher","award":["212250-2102-10209-01-15"],"award-info":[{"award-number":["212250-2102-10209-01-15"]}],"id":[{"id":"10.13039\/501100007686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and objectives: Thyroid autoimmunity (TAI) has been associated with a significantly increased risk of miscarriage in women with recurrent pregnancy loss (RPL). The aim of this study was to determine the prevalence of TAI in women with RPL and compare the clinical characteristics of positive and negative TAI women. Materials and Methods: This is a retrospective cross-sectional study; 203 women with RPL were included. Thyroid profile, anti-thyroid peroxidase (TPO-Ab), and anti-thyroglobulin (TG-Ab) antibodies were measured in all participants. Clinical characteristics and causes of RPL were compared between positive and negative TAI. Results: Prevalence of TAI was 14.8%; prevalence of positive TPO-Ab and TG-Ab was 12.3% and 4.9%, respectively. Women with TAI had significantly higher concentrations of thyrotropin (TSH) compared to women without TAI (4.8 \u00b1 3.8 versus 3.1 \u00b1 1.1, p = 0.001). There was no significant difference in age, the number of gestations, miscarriages, state of antiphospholipid antibodies (aPL), or causes of RPL between women that were TAI-positive versus TAI-negative. Prevalence of positive TAI by cause of RPL was: endocrine 7\/25 (28%), genetic 1\/5 (20%), autoimmune 1\/5 (20%), anatomic 8\/55 (14.5%), and unexplained cause 13\/112 (11.6%). Conclusions: The prevalence of TAI in women with RPL is 14.8%. Women with an endocrine cause have the highest prevalence of TAI.<\/jats:p>","DOI":"10.3390\/medicina57020096","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T03:31:30Z","timestamp":1611286290000},"page":"96","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Prevalence of Thyroid Autoimmunity in Women with Recurrent Pregnancy Loss"],"prefix":"10.3390","volume":"57","author":[{"given":"Myrna Souraye","family":"Godines-Enriquez","sequence":"first","affiliation":[{"name":"Education in Health Sciences, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Miranda-Vel\u00e1squez","sequence":"additional","affiliation":[{"name":"Reproductive Gynecology Department, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Magdalena","family":"Enr\u00edquez-P\u00e9rez","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidia","family":"Arce-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nayeli","family":"Mart\u00ednez-Cruz","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6341-6893","authenticated-orcid":false,"given":"Claudia Montserrat","family":"Flores-Robles","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Aguayo-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Reproductive Gynecology Department, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fela Vanessa","family":"Morales-Hern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Reproductive Gynecology Department, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma","family":"Villarreal-Barranca","sequence":"additional","affiliation":[{"name":"Coordination of Education and Research, Hospital de la Mujer, Ministry of Health, Mexico City 11340, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca Vianey","family":"Su\u00e1rez-Rico","sequence":"additional","affiliation":[{"name":"Direction of Research, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araceli","family":"Montoya-Estrada","sequence":"additional","affiliation":[{"name":"Coordination of Gynecological and Perinatal Endocrinology, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1145-533X","authenticated-orcid":false,"given":"Jos\u00e9","family":"Romo-Y\u00e1\u00f1ez","sequence":"additional","affiliation":[{"name":"Coordination of Gynecological and Perinatal Endocrinology, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5304-7476","authenticated-orcid":false,"given":"Enrique","family":"Reyes-Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Coordination of Gynecological and Perinatal Endocrinology, National Institute of Perinatology, Ministry of Health, Mexico City 11000, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0140-6736(90)92159-F","article-title":"Recurrent miscarriage I: Definition and epidemiology","volume":"336","author":"Stirrat","year":"1990","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bpobgyn.2014.12.001","article-title":"Recurrent pregnancy loss and obesity","volume":"29","year":"2015","journal-title":"Best Pr. Res. Clin. Obs. Gynaecol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Akhtar, M., Agrawal, R., Brown, J., Sajjad, Y., and Craciunas, L. (2019). Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism. Cochrane Database Syst. Rev., 1\u201339.","DOI":"10.1002\/14651858.CD011009.pub2"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.fertnstert.2009.01.166","article-title":"Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses","volume":"93","author":"Jaslow","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1447-0756.2009.01079.x","article-title":"Recurrent pregnancy loss: A disease of inflammation and coagulation","volume":"35","author":"Yang","year":"2009","journal-title":"J. Obs. Gynaecol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/aji.12234","article-title":"Immunological modes of pregnancy loss: Inflammation, immune effectors, and stress","volume":"72","author":"Bao","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1210\/jc.2007-0141","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: An Endocrine Society Clinical Practice Guideline","volume":"92","author":"Abalovich","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.fertnstert.2019.11.003","article-title":"Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss: A systematic review and meta-analysis","volume":"113","author":"Dong","year":"2020","journal-title":"Fertil. Steril."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2265.2010.03974.x","article-title":"Thyroid autoimmunity and miscarriage: A meta-analysis","volume":"74","author":"Chen","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_10","first-page":"1807","article-title":"Effects of Thyroid diseases on pregnancy outcomes","volume":"18","author":"Zhou","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_11","first-page":"1","article-title":"Impact of levothyroxine therapy on obstetric, neonatal and childhood outcomes in women with subclinical hypothyroidism diagnosed in pregnancy; a systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Yamamoto","year":"2018","journal-title":"BMJ Open"},{"key":"ref_12","first-page":"2596","article-title":"Maternal characteristics and outcomes affected by hypothyroidism during pregnancy (maternal hypothyroidism on pregnancy outcomes, MHPO-1)","volume":"19","author":"Kiran","year":"2019","journal-title":"BMV"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ijgo.12745","article-title":"Good clinical practice advice: Thyroid and pregnancy","volume":"144","year":"2019","journal-title":"Int. J. Gynecol. Obs."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/humrep\/17.4.940","article-title":"Cumulative delivery rates after ICSI in women aged >37 years","volume":"17","author":"Osmanagaoglu","year":"2002","journal-title":"Hum. Reprod."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.2000.01087.x","article-title":"Thyroid disease in relation to pregnancy: A decade of change","volume":"53","author":"Lazarus","year":"2001","journal-title":"Clin. Endocrinol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1210\/jc.2005-1603","article-title":"Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: Effects on obstetrical complications","volume":"91","author":"Negro","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"ESHRE Guideline Group on RPL, Atik, R.B., Christiansen, O.B., Elson, J., Kolte, A.M., Lewis, S., Middeldorp, S., Nelen, W., Peramo, B., and Quenby, S. (2018). ESHRE guideline: Recurrent pregnancy loss. Hum. Reprod. Open, 2018, hoy004.","DOI":"10.1093\/hropen\/hoy004"},{"key":"ref_18","unstructured":"Regan, L., Backos, M., and Rai, R. (2011). The Investigation and Treatment of Couples with Recurrent First-Trimester and Second-Trimester Miscarriage, Royal College of Obstetricians and Gynaecologists. RCOG Green Top Guideline."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0002-9378(12)90830-3","article-title":"Antithyroid antibodies and the association with non-organ-specific antibodies in recurrent pregnancy loss","volume":"168","author":"Pratt","year":"1993","journal-title":"Am. J. Obs. Gynecol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/09513590.2019.1653564","article-title":"Does subclinical hypotthyroidism and\/or thyroid autoimmunity influence the IVF\/ICSI outcome?Review of the literature","volume":"35","author":"Khachikovna","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/oxfordjournals.humrep.a135823","article-title":"Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions","volume":"10","author":"Bussen","year":"1995","journal-title":"Hum. Reprod."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0301-2115(97)00097-3","article-title":"Thyroid antibodies and their relation to antithrombin antibodies, anticardiolipin antibodies and lupus anticoagulant in women with recurrent spontaneous abortions (antithyroid, anticardiolipin and antithrombin autoantibodies and lupus anticoagulant in habitual aborters)","volume":"74","author":"Bussen","year":"1997","journal-title":"Eur. J. Obs. Gynecol. Reprod. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1600-0897.1996.tb00503.x","article-title":"Laboratory evaluation of women experiencing reproductive failure","volume":"35","author":"Roussev","year":"1996","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0015-0282(99)00091-6","article-title":"Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction","volume":"71","author":"Kutteh","year":"1999","journal-title":"Fertil. Steril."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0015-0282(98)00509-3","article-title":"Thyroid antibody titer and avidity in patients with recurrent miscarriage","volume":"71","author":"Wilson","year":"1999","journal-title":"Fertil. Steril."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0897.2011.01021.x","article-title":"Thyroid autoimmunity and recurrent miscarriage","volume":"66","author":"Ticconi","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.fertnstert.2012.04.025","article-title":"Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: Prevalence, prognostic value, and response to empirical thyroxine therapy","volume":"98","author":"Yan","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/09513590.2015.1092513","article-title":"Live-birth rate in euthyroid women with recurrent miscarriage and thyroid peroxidase antibodies","volume":"32","author":"Vissenberg","year":"2016","journal-title":"Gynecol. Endocrinol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.rbmo.2019.11.014","article-title":"Prevalence of thyroid autoimmunity and effect of levothyroxine treatment in a cohort of 1064 patients with recurrent pregnancy loss","volume":"40","author":"Iews","year":"2020","journal-title":"Reprod. Biomed. Online"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"key":"ref_31","first-page":"361","article-title":"There is no association between the presence of anti-thyroid antibodies and increased reproductive loss in pregnant women after ART: A systematic review and meta-analysis","volume":"21","author":"Leiva","year":"2017","journal-title":"JBRA Assist. Reprod."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/2\/96\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:13:50Z","timestamp":1760159630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/57\/2\/96"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["medicina57020096"],"URL":"https:\/\/doi.org\/10.3390\/medicina57020096","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]}}}